Revolution MD

Revolution MD

Early Stage

Reinventing Medication Delivery

Reinventing Medication Delivery

Overview

Raised to Date: Raised: $59,322

Total Commitments ($USD)

Platform

StartEngine

Start Date

12/30/2021

Close Date

07/27/2022

Min. Goal
$10,000
Max. Goal
$1,070,000
Min. Investment

$250

Security Type

Equity - Common

Series

Pre-Seed

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$2.00

Pre-Money Valuation

$26,712,500

Rolling Commitments ($USD)

Status
Funded
Reporting Date

07/30/2022

Days Remaining
Funded
% of Min. Goal
Funded
% of Max. Goal
Funded
Likelihood of Max
Funded
Avg. Daily Raise

$284

# of Investors

82

Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded

2018

Industry

Healthcare & Pharmaceuticals

Tech Sector

HealthTech

Distribution Model

B2B

Margin

Medium

Capital Intensity

Low

Location

Knoxville, Tennessee

Business Type

Growth

Revolution MD, with a valuation of $26.7 million, is raising funds on StartEngine. The company is reinventing medication delivery with its patent-pending smart inhaler. The inhaler, INHALE, is safely designed to control the dispensing of opioids and provide immediate pain relief along with minimizing the risk of addiction. Revolution MD plans to submit the pre-IND to the FDA and complete the device for clinical trials. Josh Kimmel founded Revolution MD in August 2018. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $1,070,000. The campaign proceeds will be used for FDA approvals and clinical trials.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$0

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$-101,611

$-201,257

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$3,693

$48,743

Accounts Receivable

$0

$0

Total Assets

$5,017

$48,743

Short-Term Debt

$0

$0

Long-Term Debt

$0

$0

Total Liabilities

$0

$0

Financials as of: 12/30/2021
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.

Create your first portfolio

Create your own startup investment portfolio on KingsCrowd.

Track all of your startup investments in one place using our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
Revolution MD on StartEngine 2021
Platform: StartEngine
Security Type: Equity - Common
Valuation: $26,712,500
Price per Share: $2.00

Follow company

Follow Revolution MD on StartEngine 2021

Buy Revolution MD's Deal Report

Warning: according to the close date for this deal, Revolution MD may no longer be accepting investments.

Revolution MD Deal Report

Get KingsCrowd’s comprehensive report on Revolution MD including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Revolution MD is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Revolution MD deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge